Neumora Therapeutics
NMRA
NMRA
115 hedge funds and large institutions have $65.2M invested in Neumora Therapeutics in 2025 Q1 according to their latest regulatory filings, with 33 funds opening new positions, 31 increasing their positions, 30 reducing their positions, and 50 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
115
Holders Change
-19
Holders Change %
-14.18%
% of All Funds
1.56%
Holding in Top 10
1
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-66.67%
% of All Funds
0.01%
New
33
Increased
31
Reduced
30
Closed
50
Calls
$282K
Puts
$130K
Net Calls
+$152K
Net Calls Change
-$2.42M
Top Buyers
| 1 |
UBS Group
Zurich,
Switzerland
|
+$1.86M |
| 2 |
TCM
Tang Capital Management
San Diego,
California
|
+$1.4M |
| 3 |
Renaissance Technologies
New York
|
+$1.26M |
| 4 |
GCM
Graham Capital Management
Rowayton,
Connecticut
|
+$1.1M |
| 5 |
Bank of America
Charlotte,
North Carolina
|
+$774K |
